Aurobindo Pharma gets US nod for Stavudine

Written by Agencies | Mumbai | Updated: Dec 31 2008, 19:51pm hrs
Drug maker Aurobindo Pharma on Wednesday said it has received approvals from US drug regulator for Stavudine capsules and Stavudine oral solution, which are used in the treatment of HIV-1 infection.

The company has received nod from the US Food and Drug Administration (USFDA) for Stavudine capsules and Stavudine for oral solution used for treating HIV-1infection, Aurobindo Pharma said in a filing to the Bombay Stock Exchange.

Further, the company has received the US regulator's approval for Stavudine capsules in the strengths of 15 mg, 20 mg, 30 mg and 40 mg and Stavudine oral solution in 1 mg or 1 ml.

On December 22, the pharmaceutical firm had received a tentative new drug approval from USFDA for its fixed dose combination drug product Lamivudine, Zidovudine and Nevirapine tablets used in the treatment of HIV-1 infection.

Shares of the company were trading at Rs 167.05, up 3.69 per cent on the BSE.